HIV-1 entry inhibitors: Evading the issue

被引:0
|
作者
Nelson L. Michael
John P. Moore
机构
[1] Walter Reed Army Institute of Research,
[2] The Aaron Diamond AIDS Research Center,undefined
[3] The Rockefeller University,undefined
来源
Nature Medicine | 1999年 / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
HIV-1 entry into cells is an attractive target for new antiviral agents. But will inhibitors aimed at the CCR5 co-receptor force HIV-1 to evolve more virulent forms?
引用
收藏
页码:740 / 742
页数:2
相关论文
共 50 条
  • [31] Inhibitors of HIV-1 Entry and Integration: Recent Developments and Impact on Treatment
    Sharma, Anil K.
    George, Varghese
    Valiathan, Ranjini
    Pilakka-Kanthikeel, Sudheesh
    Pallikkuth, Suresh
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2013, 7 (02) : 151 - 161
  • [32] HIV-1 entry inhibitors: Classes, applications and factors affecting potency
    Sterjovski, Jasminka
    Churchill, Melissa J.
    Wesselingh, Steve L.
    Gorry, Paul R.
    CURRENT HIV RESEARCH, 2006, 4 (04) : 387 - 400
  • [33] Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors
    Dang, Zhao
    Zhu, Lei
    Lai, Weihong
    Bogerd, Hal
    Lee, Kuo-Hsiung
    Huang, Li
    Chen, Chin-Ho
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (03): : 240 - 244
  • [34] Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
    Moore, John P.
    RETROVIROLOGY, 2006, 3
  • [35] Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors
    Rudick, Jonathan G.
    Laakso, Meg M.
    Schloss, Ashley C.
    DeGrado, William F.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (41) : 7096 - 7100
  • [36] Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
    John P Moore
    Retrovirology, 3 (Suppl 1)
  • [37] Endocytic entry of HIV-1
    Fackler, OT
    Peterlin, BM
    CURRENT BIOLOGY, 2000, 10 (16) : 1005 - 1008
  • [38] STUDIES ON HIV-1 ENTRY
    ROBINSON, HL
    FERNANDEZLARSSON, R
    LU, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S84 - S84
  • [39] Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants
    Dang, Zhao
    Qian, Keduo
    Ho, Phong
    Zhu, Lei
    Lee, Kuo-Hsiung
    Huang, Li
    Chen, Chin-Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (16) : 5190 - 5194
  • [40] Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors
    De Feo, Christopher J.
    Weiss, Carol D.
    VIRUSES-BASEL, 2012, 4 (12): : 3859 - 3911